KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary

E. Torres, Vicente; Ahn, Curie; R.M. Barten, Thijs; Brosnahan, Godela; A. Cadnapaphornchai, Melissa; B. Chapman, Arlene; Cornec-Le Gall, Émilie; P.H. Drenth, Joost; T. Gansevoort, Ron; C. Harris, Peter; Harris, Tess; Horie, Shigeo; C. Liebau, Max; Liew, Michele; Mallett, Andrew; Mei, Changlin; Mekahli, Djalila; Odland, Dwight; Ong, Albert; F. Onuchic, Luiz; Pei, York; D. Perrone, Ronald; K. Rangan, Gopala; Rayner, Brian; Torrá, Roser; M. Balk, Ethan; E. Gordon, Craig; Earley, Amy; A. Mustafa, Reem; Devuyst, Olivier

doi:10.1016/j.kint.2024.07.010

Public

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary

Published in Kidney International • Jan 21, 2025

Authors:

Vicente E. Torres

Curie Ahn

Thijs R.M. Barten

Abstract

The Kidney Disease: Improving Global Outcomes (KDIGO) 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) represents the first KDIGO guideline on this subject. Its scope includes nomenclature, diagnosis, prognosis, an...

Subject

Guideline

Autosomal dominant polycystic kidney disease

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!